novartis

Vivian Announces Partnership with Novartis Pharma Services AG in Malta

Vivian has entered into a distribution agreement with worldwide R&D pharmaceutical company Novartis Pharma Services AG, a move that continues to reflect Vivian’s established reputation as a trusted partner for…

Read More Here

Novartis working on pan-coronavirus oral treatment, CEO says

Dec 6 (Reuters) - Novartis hopes to still play a role in the development of COVID-19 treatments with research ongoing for a pill that could work broadly against coronaviruses, not…

Read More Here

Novartis CEO says it will take more than vaccines to fight COVID

Vaccines alone will not be enough to fight Covid-19, Novartis AG Chief Executive Officer Vas Narasimhan said. Treatments will also play a crucial role. Significant supplies of highly effective vaccines…

Read More Here

Novartis halts malaria drug trial against COVID-19

Swiss drugmaker Novartis is halting its trial of malaria drug hydroxychloroquine (HCQ) against COVID-19 after struggling to find participants, it said on Friday, as data emerged from other studies raising…

Read More Here

Novartis to sponsor large clinical trial of hydroxychloroquine in hospitalized COVID-19 patients

Novartis has reached an agreement with the US Food and Drug Administration (FDA) to proceed with a Phase III clinical trial with approximately 440 patients to evaluate the use of…

Read More Here

Novartis announces plan to initiate clinical study of Jakavi in severe COVID-19 patients

Novartis announced plans to initiate a Phase III clinical trial in collaboration with Incyte to evaluate the use of Jakavi (ruxolitinib) for treatment of a type of severe immune overreaction…

Read More Here

Novartis donates 20,000 doses of hydroxychloroquine for COVID-19 PEP clinical trial

Novartis announced today that it is donating 20,000 doses of hydroxychloroquine to the University of Washington for a COVID-19 PEP clinical trial. Sandoz, the company’s generics and biosimilars division, is…

Read More Here

Novartis steps up coronavirus fight as part of new collaboration

Several big pharmaceutical companies have joined forces with the Bill & Melinda Gates Foundation to scale up solutions and support health systems in response to the coronavirus pandemic. Basel-based pharmaceutical…

Read More Here

Novartis and Microsoft to develop drugs using AI

Swiss pharmaceutical firm Novartis and computer giant Microsoft have signed a five-year partnership deal aimed at transforming the Basel-based pharma’s business - from finance to manufacturing - using artificial intelligence.…

Read More Here